To explore the effects of LDHC mRNA on efficacy evaluation and recurrence monitoring, pre- and post-treatment LDHC mRNA expressions in the serum and exosomes of HCC patients were quantitated. This evidence concerns the gene LDHC and hepatocellular carcinoma.